Urinary system excretion of albendazole sulfoxide is a minor elimination path with less than 1 % of the dose recovered in the urine. No mention was made from damaging reactions in the breastfed babies. Albendazole ought to be ceased in all patients if medically considerable decreases in blood cell counts occur. The client needs to be apprised of the possible hazard to the fetus if pregnancy takes place while taking this medication. Albendazole did not negatively have an effect on male or female fertility in the rat at a dental dose of 30 mg/kg/day (0.32 times the recommended human dosage based on body surface area in mg/m2).
Treatment was stopped mainly because of leukopenia (0.7 %) or hepatic irregularities (3.8 % in hydatid disease). Treatment was stopped mainly because of leukopenia (0.7 %) or hepatic irregularities (3.8 % in hydatid disease).